The Federal Communications Commission (FCC) announced today (April 6 local time) that it will not file a false information complaint against the broadcaster that broadcasts President Trump’s daily press conference,media reported. The statement is understood to be in response to an emergency petition from advocacy group Free Press.
The petition calls on the FCC to investigate “the dissemination of false video messages through radio stations across the United States.” Free Press noted in particular that the President was spreading misinformation about the efficacy of hydroxychloroquine, a drug that was wrongly advertised as a panacea for the new coronary pneumonia, which is circulating.
Hydroxychloroquine is a commonly used antimalarial drug, but for neo-conortas, it has been largely untested and has not been medically shown to be effective against the disease. However, the drug has gained widespread popularity in the media, with Fox News mentioning it more than 100 times in three days.
At the same time, the president has expressed enthusiasm for the drug’s effectiveness, which he often mentions at his daily press conferences. “In a way, it’s a very powerful drug, and it’s a very successful drug,” Trump said at a March 28 news conference. (We) have reason to believe that it will succeed here… We have achieved some great results. “
While the controversy continues, the FTC has refused to litigate the issue, arguing that if the agency were involved, it would inevitably involve the First Amendment. FTC Chairman Ajit Pai said in a statement that the federal government will not and will never investigate a special interest group that is angry about the views expressed by broadcasters on the show, “in short, we will not censor the news.” “
Free Press did not immediately respond to a request for comment.